Stelzer Laurie
CIK 0001644348
EVP & Chief Financial OfficerDirector
Filings
17
Latest May 29, 2026
Issuers covered
7
Showing
17 of 17
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Stelzer Laurie. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Stelzer Laurie has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| MRTX | Mirati Therapeutics, Inc. | 4 | Aug 10, 2023 |
| PMVP | Pmv Pharmaceuticals, Inc. | 4 | Jun 9, 2025 |
| SYRE | Spyre Therapeutics, Inc. | 4 | May 29, 2026 |
| ARNA | Arena Pharmaceuticals Inc | 2 | Mar 11, 2022 |
| MBX | Mbx Biosciences, Inc. | 1 | Jan 22, 2026 |
| SION | Sionna Therapeutics, Inc. | 1 | Jun 16, 2025 |
| SURF | Surface Oncology, Inc. | 1 | Jun 10, 2022 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|